基于网络药理学和分子对接探讨金银花改善2型糖尿病的潜在机制
Potential Mechanism of Honeysuckle in the Improving of Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking
DOI: 10.12677/ACM.2022.121058, PDF,   
作者: 刘昕宇*, 赵蕙琛, 孙 露, 张玉超:青岛大学医学院附属青岛市市立医院,山东 青岛;张钟文:山东第一医科大学第一附属医院,山东 济南;刘元涛#:山东大学齐鲁医院(青岛),山东 青岛
关键词: 金银花2型糖尿病网络药理学分子对接靶点预测信号通路Honeysuckle Type 2 Diabetes Mellitus Network Pharmacology Molecular Docking Target Prediction Signal Pathway
摘要: 目的:运用网络药理学和分子对接的方法探讨金银花改善2型糖尿病(type 2 diabetes mellitus, T2DM)的潜在机制。方法:通过检索中药系统药理学数据库与分析平台(TCMSP)获得金银花的有效成分及活性靶点,通过比对人类基因数据库(GeneCards)归纳总结金银花中具有治疗作用的核心靶点,运用String10.5构建核心靶点相互作用网络图。Cytoscape3.6.1软件绘制成分–靶点和蛋白质相互作用网络图。使用DAVID6.8数据库对核心靶点进行基因本体(GO)分析和基因百科全书(KEGG)通路富集分析。AutoDockTools1.5.6进行分子对接验证关键成分与核心靶点的结合活性。结果:获得金银花有效成分17种,活性靶点204个,与T2DM相关的靶点68个。其中,槲皮素、山奈酚、木犀草素、β-谷甾醇和豆甾醇可能是金银花改善T2DM的主要活性成分,TNF、AKT1、IL6、MAPK1、VEGFA可能是治疗的关键靶点,HIF-1、TNF、PI3K-AKT、FoXO信号通路可能与改善T2DM相关。分子对接结果显示,主要活性成分与关键靶点结合良好。结论:网络药理学和分子对接在研究金银花改善T2DM的作用机制中发挥作用,并为进一步探索提供理论参考。
Abstract: Objective: To explore the potential mechanism of Honeysuckle in improving type 2 diabetes mellitus (T2DM) based on network pharmacology and molecular docking. Methods: The effective components and active targets of Honeysuckle were obtained by using the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP). By comparing with the human gene database (GeneCards), the core targets with therapeutic effect in Honeysuckle were summarized. And the String10.5 was used to construct target interaction network. Cytoscape3.6.1 software was used to plot the component-target network and protein interaction network. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of the core targets were performed by using the David6.8 database. AutoDockTools1.5.6 conducted molecular docking to verify the binding activity between key components and core targets. Result: 17 active components, 204 active targets and 68 targets related to type 2 diabetes were obtained from Honeysuckle. Quercetin, Kaempferol, Luteolin, β-sitosterol and Stigmasterol may be the main active components of Honeysuckle in improving T2DM. TNF, AKT1, IL6, MAPK1 and VEGFA may be the key targets of treatment. HIF-1, TNF, PI3K-AKT and FoXO signaling pathways may be related to the improvement of T2DM. The results of molecular docking showed that the main active components were well combined with the key targets. Conclusions: Network pharmacology and molecular docking play roles in exploring the potential mechanism of Honeysuckle in improving T2DM, and provide theoretical reference for further research.
文章引用:刘昕宇, 赵蕙琛, 张钟文, 孙露, 张玉超, 刘元涛. 基于网络药理学和分子对接探讨金银花改善2型糖尿病的潜在机制[J]. 临床医学进展, 2022, 12(1): 381-393. https://doi.org/10.12677/ACM.2022.121058

参考文献

[1] Petersmann, A., Muller-Wieland, D., Muller, U.A., et al. (2019) Definition, Classification and Diagnosis of Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes, 127, S1-S7. [Google Scholar] [CrossRef] [PubMed]
[2] Landgraf, R., Aberle, J., Birkenfeld, A.L., et al. (2019) Therapy of Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes, 127, S73-S92. [Google Scholar] [CrossRef] [PubMed]
[3] Bailey, C.J. (2017) Metformin: Historical Overview. Diabetologia, 60, 1566-1576. [Google Scholar] [CrossRef] [PubMed]
[4] Mudaliar, S., Polidori, D., Zambrowicz, B. and Henry, R.R. (2015) Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to Bedside. Diabetes Care, 38, 2344-2353. [Google Scholar] [CrossRef] [PubMed]
[5] 孙孝忠. 《黄帝内经》对糖尿病的认识[J]. 光明中医, 2011, 26(7): 1313-1314.
[6] 闫寒冰. 中医药防治糖尿病及其并发症的研究[J]. 中国医药指南, 2020, 18(25): 38-39+42.
[7] Lin, B., Cai, B. and Wang, H. (2019) Honeysuckle Extract Relieves Ovalbumin-Induced Allergic Rhinitis by Inhibiting AR-Induced Inflammation and Autoimmunity. Bioscience Reports, 39, BSR20190673. [Google Scholar] [CrossRef
[8] Huang, Y., Liu, H., Sun, X., et al. (2019) Honeysuckle-Derived microRNA2911 Directly Inhibits Varicella-Zoster Virus Replication by Targeting IE62 Gene. Journal of NeuroVirology, 25, 457-463. [Google Scholar] [CrossRef] [PubMed]
[9] 毛淑敏, 许家珍, 焦方文, 等. 金银花多糖对免疫低下小鼠免疫功能的影响[J]. 辽宁中医药大学学报, 2016, 18(2): 18-20.
[10] 梁湘樱, 张红杰, 朱凌云, 等. 金银花提取物对小鼠肝脏和人肝细胞PGC-1α表达及胰岛素抵抗的影响[J]. 中国糖尿病杂志, 2011, 19(3): 197-200.
[11] 周文霞, 程肖蕊, 张永祥. 网络药理学: 认识药物及发现药物的新理念[J]. 中国药理学与毒理学杂志, 2012, 26(1): 4-9.
[12] 杨金伟, 喻嵘, 吴勇军, 等. 基于网络药理学探讨肾气丸干预2型糖尿病的分子机制及关键作用通路的验证[J]. 北京中医药大学学报, 2021, 44(1): 60-68.
[13] Pang, G.M., Li, F.X., Yan, Y., et al. (2019) Herbal Medicine in the Treatment of Patients with Type 2 Diabetes Mellitus. Chinese Medical Journal, 132, 78-85. [Google Scholar] [CrossRef
[14] Heng, X.P., Li, X.J., Li, L., et al. (2020) Therapy to Obese Type 2 Diabetes Mellitus: How Far Will We Go down the Wrong Road? Chinese Journal of Integrative Medicine, 26, 62-71. [Google Scholar] [CrossRef] [PubMed]
[15] Shang, X., Pan, H., Li, M., et al. (2011) Lonicera japonica Thunb.: Ethnopharmacology, Phytochemistry and Pharmacology of an Important Traditional Chinese Medicine. Journal of Ethnopharmacology, 138, 1-21. [Google Scholar] [CrossRef] [PubMed]
[16] Zhao, X., Wang, D., Qin, L., et al. (2018) Comparative Investigation for Hypoglycemic Effects of Polysaccharides from Four Substitutes of Lonicera japonica in Chinese Medicine. International Journal of Biological Macromolecules, 109, 12-20. [Google Scholar] [CrossRef] [PubMed]
[17] Jaishree, V. and Narsimha, S. (2020) Swertiamarin and Quercetin Combination Ameliorates Hyperglycemia, Hyperlipidemia and Oxidative Stress in Streptozotocin-Induced Type 2 Diabetes Mellitus in Wistar Rats. Biomedicine & Pharmacotherapy, 130, Article ID: 110561. [Google Scholar] [CrossRef] [PubMed]
[18] Zhuang, M., Qiu, H., Li, P., et al. (2018) Islet Protection and Amelioration of Type 2 Diabetes Mellitus by Treatment with Quercetin from the Flowers of Edgeworthia gardneri. Drug Design, Development and Therapy, 12, 955-966. [Google Scholar] [CrossRef
[19] Imran, M., Rauf, A., Shah, Z.A., et al. (2019) Chemo-Preventive and Therapeutic Effect of the Dietary Flavonoid Kaempferol: A Comprehensive Review. Phytotherapy Research, 33, 263-275. [Google Scholar] [CrossRef] [PubMed]
[20] Alkhalidy, H., Moore, W., Wang, A., et al. (2018) Kaempferol Ameliorates Hyperglycemia through Suppressing Hepatic Gluconeogenesis and Enhancing Hepatic Insulin Sensitivity in Diet-Induced Obese Mice. The Journal of Nutritional Biochemistry, 58, 90-101. [Google Scholar] [CrossRef] [PubMed]
[21] Zhang, L., Han, Y.J., Zhang, X., et al. (2016) Luteolin Reduces Obesity-Associated Insulin Resistance in Mice by Activating AMPKalpha1 Signalling in Adipose Tissue Macrophages. Diabetologia, 59, 2219-2228. [Google Scholar] [CrossRef] [PubMed]
[22] Li, L., Luo, W., Qian, Y., et al. (2019) Luteolin Protects against Diabetic Cardiomyopathy by Inhibiting NF-Kappab-Mediated Inflammation and Activating the Nrf2-Mediated Antioxidant Responses. Phytomedicine, 59, Article ID: 152774. [Google Scholar] [CrossRef] [PubMed]
[23] Zhang, M., He, L., Liu, J., Zhou, L., et al. (2021) Luteolin Attenuates Diabetic Nephropathy through Suppressing Inflammatory Response and Oxidative Stress by Inhibiting STAT3 Pathway. Experimental and Clinical Endocrinology & Diabetes, 129, 729-739. [Google Scholar] [CrossRef] [PubMed]
[24] Babu, S., Krishnan, M., Rajagopal, P., et al. (2020) Beta-Sitosterol Attenuates Insulin Resistance in Adipose Tissue via IRS-1/AKt Mediated Insulin Signaling in High Fat Diet and Sucrose Induced Type-2 Diabetic Rats. European Journal of Pharmacology, 873, Article ID: 173004. [Google Scholar] [CrossRef] [PubMed]
[25] Wang, J., Huang, M., Yang, J., et al. (2017) Anti-Diabetic Activity of Stigmasterol from Soybean Oil by Targeting the GLUT4 Glucose Transporter. Food & Nutrition Research, 61, Article ID: 1364117. [Google Scholar] [CrossRef] [PubMed]
[26] Son, M. and Wu, J. (2019) Egg White Hydrolysate and Peptide Reverse Insulin Resistance Associated with Tumor Necrosis Factor-α (TNF-α) Stimulated Mitogen-Activated Protein Kinase (MAPK) Pathway in Skeletal Muscle Cells. European Journal of Nutrition, 58, 1961-1969. [Google Scholar] [CrossRef] [PubMed]
[27] Huang, S., Xu, Y., Peng, W.F., et al. (2019) Asymmetric Dimethylarginine Targets MAPK Pathway to Regulate Insulin Resistance in Liver by Activating Inflammation Factors. Journal of Cellular Biochemistry, 120, 7474-7481. [Google Scholar] [CrossRef] [PubMed]
[28] Akbari, M. and Hassan-Zadeh, V. (2018) Il-6 Signalling Pathways and the Development of Type 2 Diabetes. Inflammopharmacology, 26, 685-698. [Google Scholar] [CrossRef] [PubMed]
[29] Eblen, S.T. (2018) Extracellular-Regulated Kinases: Signaling from RAS to ERK Substrates to Control Biological Outcomes. Advances in Cancer Research, 138, 99-142. [Google Scholar] [CrossRef] [PubMed]
[30] Kassouf, T. and Sumara, G. (2020) Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases. Biomolecules, 10, 1256. [Google Scholar] [CrossRef] [PubMed]
[31] Zong, J., Li, S., Wang, Y., et al. (2019) Bromodomain-Containing Protein 2 Promotes Lipolysis via ERK/HSL Signalling Pathway in White Adipose Tissue of Mice. General and Comparative Endocrinology, 281, 105-116. [Google Scholar] [CrossRef] [PubMed]
[32] Zhao, Y., Ma, S., Hu, X., et al. (2020) JAB1 Promotes Palmitate-Induced Insulin Resistance via ERK Pathway in Hepatocytes. Journal of Physiology and Biochemistry, 76, 655-662. [Google Scholar] [CrossRef] [PubMed]
[33] Wagner, H., Fischer, H., Degerblad, M., et al. (2016) Improvement of Insulin Sensitivity in Response to Exercise Training in Type 2 Diabetes Mellitus Is Associated with Vascular Endothelial Growth Factor a Expression. Diabetes & Vascular Disease Research, 13, 361-366. [Google Scholar] [CrossRef] [PubMed]
[34] Titchenell, P.M., Lazar, M.A. and Birnbaum, M.J. (2017) Unraveling the Regulation of Hepatic Metabolism by Insulin. Trends in Endocrinology & Metabolism, 28, 497-505. [Google Scholar] [CrossRef] [PubMed]
[35] 王璐, 傅力. Glut4在调控骨骼肌葡萄糖转运中的作用研究进展[J]. 中国运动医学杂志, 2020, 39(4): 326-329.
[36] Huang, X., Liu, G., Guo, J., et al. (2018) The PI3K/AKT Pathway in Obesity and Type 2 Diabetes. International Journal of Biological Sciences, 14, 1483-1496. [Google Scholar] [CrossRef] [PubMed]
[37] Yaribeygi, H., Farrokhi, F.R., Butler, A.E., et al. (2019) Insulin Resistance: Review of the Underlying Molecular Mechanisms. Journal of Cellular Physiology, 234, 8152-8161. [Google Scholar] [CrossRef] [PubMed]
[38] Gonzalez, F.J., Xie, C. and Jiang, C. (2018) The Role of Hypoxia-Inducible Factors in Metabolic Diseases. Nature Reviews Endocrinology, 15, 21-32. [Google Scholar] [CrossRef] [PubMed]
[39] Jiang, C., Kim, J.H., Li, F., et al. (2013) Hypoxia-Inducible Factor 1alpha Regulates a SOCS3-STAT3-Adiponectin Signal Transduction Pathway in Adipocytes. Journal of Biological Chemistry, 288, 3844-3857. [Google Scholar] [CrossRef
[40] Kim, D.H., Lee, B., Lee, J., et al. (2019) FoXO6-Mediated IL-1beta Induces Hepatic Insulin Resistance and Age-Related Inflammation via theTF/PAR2 Pathway in Aging and Diabetic Mice. Redox Biology, 24, Article ID: 101184. [Google Scholar] [CrossRef] [PubMed]
[41] Garcia Whitlock, A.E., Sostre-Colon, J., Gavin, M., et al. (2021) Loss of FoXO Transcription Factors in the Liver Mitigates Stress-Induced Hyperglycemia. Molecular Metabolism, 51, Article ID: 101246. [Google Scholar] [CrossRef] [PubMed]